- Home
- OPTX vs IKNA Comparison
OPTX vs IKNA Comparison
Compare OPTX & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- IKNA
- Stock Information
- Founded
- OPTX 1981
- IKNA 2016
- Country
- OPTX United States
- IKNA United States
- Employees
- OPTX N/A
- IKNA N/A
- Industry
- OPTX Blank Checks
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- IKNA Health Care
- Exchange
- OPTX Nasdaq
- IKNA Nasdaq
- Market Cap
- OPTX 51.9M
- IKNA 52.1M
- IPO Year
- OPTX N/A
- IKNA 2021
- Fundamental
- Price
- OPTX $1.46
- IKNA $1.42
- Analyst Decision
- OPTX
- IKNA Strong Buy
- Analyst Count
- OPTX 0
- IKNA 1
- Target Price
- OPTX N/A
- IKNA $4.00
- AVG Volume (30 Days)
- OPTX 62.9K
- IKNA 101.8K
- Earning Date
- OPTX 06-13-2025
- IKNA 05-08-2025
- Dividend Yield
- OPTX N/A
- IKNA N/A
- EPS Growth
- OPTX N/A
- IKNA N/A
- EPS
- OPTX 0.00
- IKNA N/A
- Revenue
- OPTX $29,392,186.00
- IKNA N/A
- Revenue This Year
- OPTX N/A
- IKNA N/A
- Revenue Next Year
- OPTX N/A
- IKNA N/A
- P/E Ratio
- OPTX $840.96
- IKNA N/A
- Revenue Growth
- OPTX 4.36
- IKNA N/A
- 52 Week Low
- OPTX $0.85
- IKNA $0.97
- 52 Week High
- OPTX $8.39
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- OPTX 46.02
- IKNA 70.01
- Support Level
- OPTX $1.51
- IKNA $1.10
- Resistance Level
- OPTX $1.59
- IKNA $1.40
- Average True Range (ATR)
- OPTX 0.17
- IKNA 0.07
- MACD
- OPTX -0.03
- IKNA 0.03
- Stochastic Oscillator
- OPTX 22.41
- IKNA 97.20
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.